Clinical Trial Update: Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. [Phase 2]

View source ↗

Summary

A Phase 2 trial in metastatic HER2-positive breast cancer is investigating whether treatment can be reduced for patients who have undetectable cancer levels in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Breast Cancer, HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING